SEARCH

SEARCH BY CITATION

References

  • Boelaert M, Le Ray D & Van Der Stuyft P (2002) How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Tropical Medicine and International Health 7, 955959.
  • Bryceson A (2001) A policy for leishmaniasis with respect to the prevention and control of drug resistance. Tropical Medicine and International Health 6 (11), 928934.
  • Cerf BJ, Jones, TC, Badaro R, Sampaio D, Teixeira R & Johnson WD (1987) Malnutrition as a risk factor for severe visceral leishmaniasis. Journal of Infectious Diseases 156 (6), 10301033.
  • Chin J & Ascher MS (2000) Control of communicable disease manual, 17th edn. American Public Health Association, Washington, US, p. 288.
  • Dereure J, Boni M, Pratlong F et al. (2000) Visceral leishmaniasis in Sudan: first identification of Leishmania from dogs. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 154155.
  • Desjeux P (1996) Leishmaniasis: Public health aspects and control. Clinics in Dermatology 14, 417423.
  • El-Hassan AM & Khalil EA (2001) Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan? Tropical Medicine and International Health 6 (9), 743744.
  • El-Hassan AM & Zijlstra EE (2001) Leishmaniasis in Sudan. Visceral Leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 95 (suppl.1), S1/27S1/58.
  • Elnaiem, DA, Schorscher J, Bundal A et al. (2002) Risk mapping of visceral leishmaniasis: The role of local variation of rainfall and altitude on presence and incidence of Kala Azar in eastern Sudan. American Journal of Tropical Medicine and Hygiene 66 (6), 1017.
  • Guerin PJ, Olliaro P, Sundar S et al. (2002) Visceral leishmaniasis: current status of control, diagnosis and treatment, and a proposed research and development agenda. Lancet Infectious Diseases 2 (8), 494501.
  • Hoogstraal H & Heynemann D (1969) Leishmaniasis in the Sudan Republic. American Journal of Tropical Medicine and Hygiene 18, 10911210.
  • Lyons S, Veeken H & Long J. (2003) Visceral leishmaniasis and HIV in Tigray, Ethiopia. Tropical Medicine and International Health 8 (8), 733739.
  • McMichael AJ (2000) The urban environment and health in a world of increasing globalization: issues for developing countries. Bulletin of the World Health Organization 78 (9), 11171126.
  • MSF (2003) Manual for the diagnosis and treatment of visceral leishmaniasis (Kala Azar) under field conditions. MSF-Holland, Amsterdam, Holland.
  • Mukhtar MM, Sharief AH & El-Safi SH et al. (2000) Detection of Antibodies to Leishmania donovani in animals in a Kala Azar endemic region in eastern Sudan: a preliminary report. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 3336.
  • Ritmeijer K & Davidson RN (2003) Royal Society of Tropical Medicine and Hygiene joint meeting with Medecins Sans Frontieres at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Medecins Sans Frontieres interventions against kala-azar in the Sudan, 1989–2003. Transactions of the Royal Society of Tropical Medicine and Hygiene 97 (6), 609613.
  • Seaman J, Ashford RW, Schorscher J & Dereure J (1992) Visceral Leishmaniasis in Southern Sudan: status of healthy villagers in epidemic conditions. Annuals of Tropical Medicine and Parasitology 86 (5), 481486.
  • Seaman J, Mercer AJ & Sondorp E (1996) The Epidemic of Visceral Leishmaniasis in Western Upper Nile, Southern Sudan: Course and Impact from 1984 to 1994. International Journal of Epidemiology 25, 862871.
  • Thakur CP (2000) Socio-economics of visceral Leishmaniasis in Bihar (India). Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 156157.
  • Veeken H, Ritmeijer K, Seaman J, Davidson R (2000) A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. Tropical Medicine and International Health 5 (5), 312317.
  • WHO (2001) The Leishmaniasis and Leishmania/HIV Co-Infections. Chapter 10 of the WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases, World Health Organization, Geneva, Switzerland.
  • Wolday D, Berthe N, Akuffo H & Britton S (1999) Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitology Today 15, 182187.
  • World Bank (2000/01) World Development Report 2000/2001: Attacking Poverty. World Bank Publications, Washington DC, US.